Yüklüyor......
IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model
Tumor-targeted antibody therapy has had a major impact on reducing morbidity and mortality in a wide range of cancers. Antibodies mediate their antitumor activity in part by activating immune effector cells; however, the tumor microenvironment (TME) is enriched with cellular and soluble mediators th...
Kaydedildi:
| Yayımlandı: | Cancer Immunol Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221424/ https://ncbi.nlm.nih.gov/pubmed/25204776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|